ABN Amro Investment Solutions Takes Position in Amrize Ltd $AMRZ

ABN Amro Investment Solutions purchased a new stake in shares of Amrize Ltd (NYSE:AMRZ) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 23,060 shares of the company’s stock, valued at approximately $1,292,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in AMRZ. Oslo Pensjonsforsikring AS bought a new position in shares of Amrize in the first quarter valued at approximately $133,000. DJE Kapital AG increased its position in shares of Amrize by 45.9% during the 1st quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after purchasing an additional 350,149 shares during the last quarter. KBC Group NV raised its stake in shares of Amrize by 199.1% during the 1st quarter. KBC Group NV now owns 33,026 shares of the company’s stock worth $1,850,000 after purchasing an additional 21,985 shares during the period. SEB Asset Management AB purchased a new position in shares of Amrize in the 1st quarter worth about $6,242,000. Finally, Swiss National Bank boosted its holdings in shares of Amrize by 7.1% in the 1st quarter. Swiss National Bank now owns 1,460,874 shares of the company’s stock worth $81,838,000 after buying an additional 96,800 shares during the last quarter.

Amrize Stock Performance

NYSE AMRZ opened at $49.25 on Friday. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a fifty day moving average of $52.09 and a 200-day moving average of $55.11. The company has a market capitalization of $27.24 billion and a P/E ratio of 23.56. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The firm had revenue of $2.18 billion during the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.Amrize’s revenue was up 4.7% compared to the same quarter last year. As a group, equities research analysts predict that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Insider Activity

In other Amrize news, insider Mario Gross bought 1,200 shares of Amrize stock in a transaction dated Wednesday, May 20th. The shares were purchased at an average cost of $48.63 per share, with a total value of $58,356.00. Following the completion of the purchase, the insider owned 34,747 shares of the company’s stock, valued at approximately $1,689,746.61. This represents a 3.58% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CTO Roald Brouwer purchased 1,500 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The stock was acquired at an average cost of $49.84 per share, with a total value of $74,760.00. Following the purchase, the chief technology officer directly owned 19,757 shares of the company’s stock, valued at $984,688.88. This trade represents a 8.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 54,920 shares of company stock valued at $2,717,429. Company insiders own 0.54% of the company’s stock.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of a number of research analyst reports. Citigroup decreased their price objective on shares of Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a report on Monday, May 4th. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Stephens reaffirmed an “overweight” rating and issued a $65.00 price target on shares of Amrize in a report on Monday, May 18th. Finally, Truist Financial reiterated a “hold” rating and issued a $48.00 price objective (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $62.79.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.